Subsequently, 3,435 DEGs were consistently upregulated or downregulated, and 3 DEmiRNAs were consistently upregulated or downregulated in both sets of differential expression data; these were defined as the genes whose expression was dysregulated in BRCA patients and the DEmiRNAs associated with high expression of ADSS (Figure 3B). This evidence concerns the gene ADSS2 and invasive breast carcinoma.